GLP Watchdog

Noom vs Willow

Neither Noom nor Willow has an FDA warning letter on record. On compounded semaglutide injection, Noom costs $1,440 less a year at standing rates: $179 a month against $299 a month at Willow.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Noom / Willow

Noom logo

Noom

5.8/10

Willow logo

Willow

7.3/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$299/moCompounded semaglutide injection
States
No state list published
35 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Noom
Visit Willow

Neither Noom nor Willow pays us. Links to them earn nothing. Scores: Noom 5.8, Willow 7.3. How we are paid

What the record shows

  1. 01

    Neither Noom nor Willow has an FDA warning letter on record.

  2. 02

    Willow names five pharmacies. Noom names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Noom costs $1,440 less a year at standing rates: $179 a month against $299 a month at Willow.

  4. 04

    Only Noom lists a price for brand-name tirzepatide pen. Only Willow lists a price for compounded tirzepatide injection.

  5. 05

    Willow lists 35 states. Noom publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Noom

Willow

Compounded semaglutide injection

$179/moLower

$2,148 a year

$299/mo

$3,588 a year

Compounded tirzepatide injection
Not sold or not priced

$399/mo

$4,788 a year

Brand-name tirzepatide pen

$349/mo

$4,188 a year

Not sold or not priced
Price includes
Clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
Not stated
None
Refunds
Refunds only before a prescription is written; renewal charges are not refunded
Full refund if you cancel before the prescription is sent to the pharmacy; none once the medication is compounded

Read off each seller’s own pages. Noom: October 30, 2026. Willow: July 10, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Noom

5.8/10
  • $1,440 a year less on compounded semaglutide injection
  • Sells brand-name tirzepatide pen, which Willow does not price
  • Names no compounding pharmacy
  • Publishes no state list
Visit Noom

The case for Willow

7.3/10
  • Sells compounded tirzepatide injection, which Noom does not price
  • Names its compounding pharmacy
Visit Willow

Scores

Noom 5.8 · Willow 7.3 out of 10. Six weighted parts.

Value25%

0.9A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
9.0

Accessibility10%

5.0A
vs
B
7.6

Support10%

4.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Noom vs Willow: questions

Neither Noom nor Willow has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Willow names five pharmacies. Noom names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Noom, by $1,440 a year at standing rates. Noom: $179 a month, about $2,148 a year. Willow: $299 a month, about $3,588 a year.
Noom states you can cancel at any time; refunds: refunds only before a prescription is written; renewal charges are not refunded. Willow states you can cancel at any time; refunds: full refund if you cancel before the prescription is sent to the pharmacy; none once the medication is compounded.
Neither Noom nor Willow pays us. Links to them earn nothing. Scores: Noom 5.8, Willow 7.3.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks